Adalvo proudly announces a significant milestone in its operational performance, setting a new record by releasing a total of 221 batches during March 2024, surpassing previous benchmarks by 42%.
This achievement showcases Adalvo's commitment to excellence and efficiency. The significant increase in batch releases reflects our growth trajectory and ability to adapt to the evolving demands of the pharmaceutical industry.
Anil Okay, CEO of Adalvo, expressed his gratitude, stating, "This achievement is a testament to the dedication and hard work of our teams. Their relentless efforts have propelled Adalvo to new heights."
As Adalvo continues on its path of growth and success, we remain committed to upholding our values of integrity, smart collaboration, and our commitment to being always on target.
We extend our heartfelt gratitude to all our employees for their exceptional performance and dedication. Their collective efforts have been instrumental in achieving this significant milestone, further solidifying Adalvo's reputation for excellence and innovation.
Partner up now!
At Adalvo, there are no half-measures – we are always on target. When your mission is to be faster and stronger than your competitors, you need a winning team driving your vision forward.